- Advertisement -

Annual Review of Cancer Biology uses Subscribe to Open to publish 2020 volume open access

Pilot OA program generates widespread support from institutional subscribers Credit: Annual Reviews Nonprofit publisher Annual Reviews is pleased...

FDA Approves Lilly’s Amyloid-Targeting Kisunla for Early Alzheimer’s

The FDA today approved Eli Lilly’s early Alzheimer’s disease drug Kisunla (donanemab-azbt), a once-monthly injection treatment indicated for adults with early symptomatic Alzheimer’s disease...

Oncotarget: Loss of CPAP in oral cancer

CPAP also plays a vital role in suppressing tumorigenesis in OSCC by facilitating EGFR homeostasis Credit: Correspondence to – Radhika Gudi – gudi@musc.edu and Chenthamarakshan...

Short term “prehabilitation” strength exercises, undertaken pre-surgery, do not prevent muscle...

Older adults about to undergo elective surgery should undertake a sustained program of targeted exercise beforehand to counteract the muscle-wasting effects of bedrest, new...

Next-Gen BLI Technology Accelerating Antibody Discovery

View eBook  The development of antibodies for diagnostics or therapeutics requires comprehensive characterization of affinity, specificity, and mechanism of action (doi.org/10.1016/j.xpro.2021.100836). Affinity measurements screen different...

Brainstem nerve cells found to stabilize blood pressure fluctuations

Doctors usually focus on a person's average blood pressure, but research increasingly shows that how much blood pressure fluctuates from moment to moment is...

TraceIQ Launched to Maximize Pharmaceutical Traceability

Systech launched TraceIQ, an intelligent, enterprise traceability platform designed to address the evolving operational aspects of pharmaceutical and biopharma supply chains. The first generation of...

Single-Use Comes of Age—What’s Next?

For much of the past two decades, the biopharmaceutical industry has assessed single-use technologies in terms of adoption: When would they replace stainless steel?...

TraceIQ Launched to Maximize Pharmaceutical Traceability

Systech launched TraceIQ, an intelligent, enterprise traceability platform designed to address the evolving operational aspects of pharmaceutical and biopharma supply chains. The first generation of...

Single-Use Comes of Age—What’s Next?

For much of the past two decades, the biopharmaceutical industry has assessed single-use technologies in terms of adoption: When would they replace stainless steel?...

StockWatch: Revolution Shares Stay Flat Despite Historic FDA Approval of Oral Pancreatic Cancer Therapy

Revolution Medicines (Nasdaq: RVMD) appeared to have the makings of another strong stock surge this past week when the FDA approved the company’s historic...

more new items

TraceIQ Launched to Maximize Pharmaceutical Traceability

Systech launched TraceIQ, an intelligent, enterprise traceability platform designed to address the evolving operational aspects of pharmaceutical and biopharma supply chains. The first generation of...

Single-Use Comes of Age—What’s Next?

For much of the past two decades, the biopharmaceutical industry has assessed single-use technologies in terms of adoption: When would they replace stainless steel?...

StockWatch: Revolution Shares Stay Flat Despite Historic FDA Approval of Oral...

Revolution Medicines (Nasdaq: RVMD) appeared to have the makings of another strong stock surge this past week when the FDA approved the company’s historic...